{"title":"新型酚醚(Su-13437, CIBA)降血脂作用的初步评价","authors":"M.M. Best, C.H. Duncan","doi":"10.1016/S0368-1319(69)80088-8","DOIUrl":null,"url":null,"abstract":"<div><p>A new phenolic ether (Su-13437, CIBA) which has been reported to be hypolipidemic in the rat has been given to 8 volunteer subjects for an 8-week period. A reduction in serum triglyceride and to a lesser extent cholesterol and phospholipid occurred in 7 of the 8 subjects.</p></div>","PeriodicalId":78351,"journal":{"name":"Journal of atherosclerosis research","volume":"10 1","pages":"Pages 103-106"},"PeriodicalIF":0.0000,"publicationDate":"1969-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0368-1319(69)80088-8","citationCount":"9","resultStr":"{\"title\":\"Preliminary evaluation of the hypolipidemic effects in man of a new phenolic ether (Su-13437, CIBA)\",\"authors\":\"M.M. Best, C.H. Duncan\",\"doi\":\"10.1016/S0368-1319(69)80088-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>A new phenolic ether (Su-13437, CIBA) which has been reported to be hypolipidemic in the rat has been given to 8 volunteer subjects for an 8-week period. A reduction in serum triglyceride and to a lesser extent cholesterol and phospholipid occurred in 7 of the 8 subjects.</p></div>\",\"PeriodicalId\":78351,\"journal\":{\"name\":\"Journal of atherosclerosis research\",\"volume\":\"10 1\",\"pages\":\"Pages 103-106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1969-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0368-1319(69)80088-8\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of atherosclerosis research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0368131969800888\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of atherosclerosis research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0368131969800888","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preliminary evaluation of the hypolipidemic effects in man of a new phenolic ether (Su-13437, CIBA)
A new phenolic ether (Su-13437, CIBA) which has been reported to be hypolipidemic in the rat has been given to 8 volunteer subjects for an 8-week period. A reduction in serum triglyceride and to a lesser extent cholesterol and phospholipid occurred in 7 of the 8 subjects.